Dr Gill Barnett

PhD, MA, BMBCh, MRCP, FRCR

Consultant Clinical Oncologist

Special clinical interest in head, neck and thyroid cancer.

Treatments

  • Radiotherapy
  • Chemotherapy
  • Immunotherapy

NHS Hospital / current post(s)

  • Addenbrooke’s Hospital, Cambridge

Year Qualified

2013

Other clinical interests

  • Dr Barnett manages a busy NHS practice as well as being H&N Service lead. Her aim is to increase the numbers of patients going into clinical trials.
  • Particular interest in technical contouring in RT; maximizing chance of cure by consistency in identifying the treatment target, whilst minimizing toxicity.
  • Strongly committed to teaching at local and national level. Dr Barnett has developed teaching materials for national RT teaching courses and a local medical statistics course. She is a FRCR Part 1 examiner.

Research Interests

My research aim is to individualize RT prescriptions, increasing dose in tolerant patients and modifying dose in sensitive patients. My work focuses on determining factors that influence the wide variation in RT toxicity. This includes patient-related factors, e.g. smoking; treatment-related factors, and genetic factors (radiogenomics). I am a co-investigator and local PI of RAPPER, a large UK radiogenomics study, and an active member of the international radiogenomics consortium.

Professional Memberships

  • GMC
  • MDU

Awards Received

  • FRCR